// App-Quantinova.ai

: Fitusiran Reaches People's with Hemophilia and Their Caregivers’ Treatment Expectations: Qualitative Semi-Structured Interviews of Participants of ATLAS-OLE Trial (Interim analysis)

Researchers

Presenter

  • Alok Srivastava

Principal Investigators

  • Savita Rangarajan

  • Cecil Ross

  • Christina Slota

  • Dana DiBenedetti

  • Viridiana Cano

  • Shauna Andersson

  • Pronabesh Dasmahapatra

  • José Bartelt-Hofer

  • Marion Afonso

Medical Centers

  • Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • St John's Medical College Hospital, Bangalore, India

  • KJ Somaiya Super Specialty Hospital, Mumbai, India

  • Christian Medical College, Vellore, India

Locations

  • United Kingdom

  • India

  • United States

  • France

Companies

  • RTI Health Solutions

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A